Lori Berk
Impact in
-
- Sarcoma Diagnosis and Treatment
- Oral health in cancer treatment
-
- PI3K/AKT/mTOR signaling in cancer
- DNA Repair Mechanisms
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 6
-
- Chronic Myeloid Leukemia Treatments 1
- Acute Myeloid Leukemia Research 1
- Co-authors
- Victor M. Rivera (11 shared papers)Tim Clackson (6 shared papers)Kay Huebner (3 shared papers)Teresa Druck (3 shared papers)Frank G. Haluska (5 shared papers)John W. Loewy (3 shared papers)Monica M Mita (3 shared papers)Koshi Mimori (2 shared papers)
- Journals
- Blood (2 papers)Annals of Oncology (2 papers)Journal of Clinical Oncology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United StatesSwitzerlandSpain
In The Last Decade
Lori Berk
15 papers receiving 792 citations
Peers
Comparison fields: 5 of 38
- Pulmonary and Respiratory Medicine 181
- Molecular Biology 237
- Hematology 36
- Genetics 19
- Genetics 54
Countries citing papers authored by Lori Berk
This map shows the geographic impact of Lori Berk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Berk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Berk more than expected).
Fields of papers citing papers by Lori Berk
This network shows the impact of papers produced by Lori Berk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Berk. The network helps show where Lori Berk may publish in the future.
Co-authors
The 25 scholars most cited alongside Lori Berk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 215 | |
| 2 | 1999 | 107 | |
| 3 | 2011 | 94 | |
| 4 | 2009 | 78 | |
| 5 | 2001 | 55 | |
| 6 | 2009 | 51 | |
| 7 | 2010 | 38 | |
| 8 | 2012 | 34 | |
| 9 | FHITness and cancer. | 1998 | 30 |
| 10 | 2009 | 29 | |
| 11 | 2005 | 24 | |
| 12 | 2011 | 19 | |
| 13 | 2005 | 15 | |
| 14 | 2012 | 15 | |
| 15 | 2008 | 7 |
About Lori Berk
Lori Berk is a scholar working on Molecular Biology, Hematology, Genetics, Oncology and Genetics, having authored 15 papers that have together received 811 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (6 papers), Cancer-related Molecular Pathways (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Glioma Diagnosis and Treatment (1 paper), Sarcoma Diagnosis and Treatment (1 paper), Acute Myeloid Leukemia Research (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (181 citations), Molecular Biology (237 citations), Hematology (36 citations), Genetics (19 citations) and Genetics (54 citations). Lori Berk has collaborated with scholars based in United States, Switzerland and Spain. Frequent co-authors include Victor M. Rivera, Tim Clackson, Kay Huebner, Teresa Druck, Frank G. Haluska, John W. Loewy, Monica M Mita, Koshi Mimori, Carlo Maria Croce and Hansjüerg Alder. Their work appears in journals such as Blood, Annals of Oncology, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.